You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 11,844,858


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,844,858 protect, and when does it expire?

Patent 11,844,858 protects RYZUMVI and is included in one NDA.

This patent has ten patent family members in eight countries.

Summary for Patent: 11,844,858
Title:Aqueous ophthalmic solutions of phentolamine and medical uses thereof
Abstract:The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
Inventor(s):Alan R. Meyer
Assignee:Ocuphire Pharma Inc
Application Number:US17/401,604
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,844,858

Introduction

When analyzing a U.S. patent, it is crucial to understand the scope and claims of the patent, as these elements define the intellectual property rights granted to the patent holder. This article will provide a comprehensive analysis of the scope and claims of a hypothetical U.S. patent, using United States Patent 11,844,858 as a model, although the specific details of this patent are not provided here.

The Role of the U.S. Patent and Trademark Office (USPTO)

The USPTO is the agency responsible for granting U.S. patents and registering trademarks. Understanding the USPTO's processes and guidelines is essential for navigating the patent landscape[2].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of the protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Importance of Claims

Claims are the most critical part of a patent application, as they define the invention and the scope of protection. The clarity, breadth, and validity of claims are pivotal in determining the patent's overall strength and enforceability.

Analyzing Patent Claims

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial for determining the patent's scope.
  • Dependent Claims: These claims refer back to and further limit the independent claims, often adding specific details or variations.

Claim Language and Structure

The language and structure of claims are vital. Clear and concise language helps in avoiding ambiguity, while the structure ensures that the claims are logically connected and easy to understand.

Technology Fields and Patent Allowance Rates

Patent applications are categorized into various technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and Others. The allowance rates vary significantly across these fields. For instance, applications in the "Drugs and Medical Instruments" and "Computers and Communications" fields have seen a substantial decrease in allowance rates over time[1].

Patent Prosecution Process

Filing and Examination

  • Filing: The initial step involves submitting the patent application to the USPTO.
  • Examination: The USPTO reviews the application to determine if the invention meets the criteria for patentability, including novelty, non-obviousness, and utility.

Continuation Applications

Continuation applications allow applicants to pursue additional claims related to the original application. These can significantly impact the overall prosecution history and the final scope of the patent[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue in patent law, particularly for continuation-in-part applications. It ensures that multiple patents claiming the same invention or obvious variations thereof are not granted, thereby preventing the extension of patent term through multiple related patents[4].

Inter Partes Review (IPR) and Patent Validity

IPR is a process by which the validity of a patent can be challenged before the Patent Trial and Appeal Board (PTAB). This process can affect the scope and claims of a patent, as it may result in the invalidation of certain claims based on prior art or obviousness grounds[5].

Case Law and Statutory Guidelines

Understanding relevant case law and statutory guidelines is essential for interpreting patent claims and scope. For example, the Federal Circuit's decisions on ODP and IPR proceedings provide critical insights into how patents are evaluated and enforced[4][5].

Key Metrics for Evaluating Patent Scope

Independent Claim Length and Count

These metrics are used to measure the breadth of patent claims. Longer and more numerous independent claims generally indicate broader patents, which may face more scrutiny during the examination process[3].

Forward Citations and Patent Maintenance Payments

Forward citations (citations to the patent by later patents) and patent maintenance payments are indicators of a patent's impact and value. Higher forward citations and consistent maintenance payments suggest a patent with significant scope and influence[3].

Practical Implications for Patent Holders

Strategic Claim Drafting

Drafting claims that are clear, concise, and narrowly focused can improve the chances of patent grant and reduce the risk of post-grant challenges.

Monitoring and Adjusting Claims

During the prosecution process, applicants should monitor and adjust their claims based on examiner feedback and prior art discoveries to ensure the strongest possible patent.

Post-Grant Challenges

Being prepared for potential IPR challenges and other post-grant proceedings is crucial. This includes maintaining a robust portfolio of prior art and being aware of the latest legal precedents.

Key Takeaways

  • Patent Scope: Defined by the breadth and depth of the claims, which can be measured using metrics like independent claim length and count.
  • Claims: The heart of a patent application, requiring clarity, specificity, and strategic drafting.
  • Technology Fields: Allowance rates vary significantly across different fields, impacting the likelihood of patent grant.
  • Prosecution Process: Includes filing, examination, and potential continuation applications, all of which affect the final patent scope.
  • ODP and IPR: Critical considerations for ensuring the validity and enforceability of patents.
  • Metrics and Indicators: Forward citations, patent maintenance payments, and claim metrics are essential for evaluating a patent's strength and impact.

FAQs

What is the typical allowance rate for U.S. patent applications?

The overall allowance rate for U.S. patent applications is around 55.8%, though this rate has decreased over time, especially in certain technology fields[1].

How do continuation applications affect the patent prosecution process?

Continuation applications allow applicants to pursue additional claims related to the original application, which can extend the prosecution process and impact the final scope of the patent[1].

What is the significance of independent claim length and count in patent scope?

These metrics measure the breadth of patent claims. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

How does Inter Partes Review (IPR) impact patent validity?

IPR can result in the invalidation of certain claims based on prior art or obviousness grounds, affecting the scope and validity of the patent[5].

What are some key metrics for evaluating patent scope?

Key metrics include independent claim length and count, forward citations, and patent maintenance payments, which indicate the patent's impact and value[3].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. USA.gov. U.S. Patent and Trademark Office (USPTO).
  3. SSRN. Patent Claims and Patent Scope.
  4. United States Court of Appeals for the Federal Circuit. In re Cellect.
  5. United States Court of Appeals for the Federal Circuit. INTUITIVE SURGICAL, INC. v. ETHICON LLC.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,844,858

Showing 1 to 1 of 1 entries

International Family Members for US Patent 11,844,858

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2014212274 ⤷  Try for Free
Australia 2018200566 ⤷  Try for Free
Canada 2899339 ⤷  Try for Free
Denmark 2950648 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.